Matches in Wikidata for { <http://www.wikidata.org/entity/Q66061502> ?p ?o ?g. }
Showing items 1 to 33 of
33
with 100 items per page.
- Q66061502 description "clinical trial" @default.
- Q66061502 description "ensayu clínicu" @default.
- Q66061502 description "klinisch onderzoek" @default.
- Q66061502 description "клінічне випробування" @default.
- Q66061502 name "Effect of Early Use of Levosimendan Versus Placebo on Top of a Conventional Strategy of Inotrope Use on a Combined Morbidity-mortality Endpoint in Patients With Cardiogenic Shock" @default.
- Q66061502 name "Effect of Early Use of Levosimendan Versus Placebo on Top of a Conventional Strategy of Inotrope Use on a Combined Morbidity-mortality Endpoint in Patients With Cardiogenic Shock" @default.
- Q66061502 type Item @default.
- Q66061502 label "Effect of Early Use of Levosimendan Versus Placebo on Top of a Conventional Strategy of Inotrope Use on a Combined Morbidity-mortality Endpoint in Patients With Cardiogenic Shock" @default.
- Q66061502 label "Effect of Early Use of Levosimendan Versus Placebo on Top of a Conventional Strategy of Inotrope Use on a Combined Morbidity-mortality Endpoint in Patients With Cardiogenic Shock" @default.
- Q66061502 prefLabel "Effect of Early Use of Levosimendan Versus Placebo on Top of a Conventional Strategy of Inotrope Use on a Combined Morbidity-mortality Endpoint in Patients With Cardiogenic Shock" @default.
- Q66061502 prefLabel "Effect of Early Use of Levosimendan Versus Placebo on Top of a Conventional Strategy of Inotrope Use on a Combined Morbidity-mortality Endpoint in Patients With Cardiogenic Shock" @default.
- Q66061502 P1132 Q66061502-F5519180-79CA-4A20-8152-080954993507 @default.
- Q66061502 P1476 Q66061502-F71044B2-2E0B-4ABE-9ED0-246E8EAD4D7B @default.
- Q66061502 P17 Q66061502-4C8908A7-4F7D-4637-B7ED-1390AB060300 @default.
- Q66061502 P1813 Q66061502-2F202171-2861-463E-A373-E46315E27600 @default.
- Q66061502 P2899 Q66061502-B18A7999-AD1E-4363-B9EA-223DE8857750 @default.
- Q66061502 P3098 Q66061502-63C528C8-3BF7-4B97-BFED-47923CFD3B6A @default.
- Q66061502 P31 Q66061502-830CB0AE-61A0-4DF9-A8B8-E3CB89F8DC12 @default.
- Q66061502 P580 Q66061502-5A5C4578-BDC0-45AB-862A-35245B05230F @default.
- Q66061502 P582 Q66061502-7FE1ED16-1D16-489A-8A5C-0D420A8BFA8A @default.
- Q66061502 P6099 Q66061502-6336E1F9-B84B-4764-9911-DD0445E2CC3A @default.
- Q66061502 P8363 Q66061502-3E810864-4891-4DB5-9782-B5DF93019987 @default.
- Q66061502 P1132 "+610" @default.
- Q66061502 P1476 "Effect of Early Use of Levosimendan Versus Placebo on Top of a Conventional Strategy of Inotrope Use on a Combined Morbidity-mortality Endpoint in Patients With Cardiogenic Shock" @default.
- Q66061502 P17 Q142 @default.
- Q66061502 P1813 "LevoHeartShock" @default.
- Q66061502 P2899 "+18" @default.
- Q66061502 P3098 "NCT04020263" @default.
- Q66061502 P31 Q30612 @default.
- Q66061502 P580 "2019-12-01T00:00:00Z" @default.
- Q66061502 P582 "2023-07-01T00:00:00Z" @default.
- Q66061502 P6099 Q42824827 @default.
- Q66061502 P8363 Q78089383 @default.